Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07121894 · ClinicalTrials.gov registry record · NA

Ketogenic Intervention for Bipolar Depression

A NA study of Bipolar Depression, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07121894 is a NA study of Bipolar Depression that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07121894, a NA study of Bipolar Depression, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.

Conditions Studied

Interventions

  • BEHAVIORAL Ketogenic Diet

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-08-12
Est. Completion 2029-05-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07121894

The ClinicalTrials.gov registry entry for NCT07121894 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 215-participant average among 29 other Bipolar Depression trials with a reported enrollment target (86% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Ketogenic Diet is the first listed.

NCT07121894 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07121894 about?

NCT07121894 is a clinical study titled "Ketogenic Intervention for Bipolar Depression". The purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.

What is the current status of trial NCT07121894?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-12. Estimated completion is 2029-05-01.

What conditions does trial NCT07121894 study?

This clinical trial studies the following conditions: Bipolar Depression.

What interventions are being tested in trial NCT07121894?

The interventions under investigation include: Ketogenic Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT07121894?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07121894 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.